News
Medtronic's Jason Fontana offers an update on next-generation Symplicity Spyral devices, procedures and a new feature they're ...
3d
Stocktwits on MSNCMS’s Initial Proposal To Cover Renal Denervation A Win For Medtronic, Says AnalystsAnalysts are optimistic about Medtronic (MDT) after the Centers for Medicare and Medicaid Services (CMS) proposed to cover ...
On Thursday, the US Centers for Medicare & Medicaid Services (CMS) issued its proposal for covering radiofrequency- or ...
BTIG analyst Ryan Zimmerman keeps a Neutral rating on Medtronic (MDT) after Centers for Medicare and Medicaid Services ...
CMS proposed Medicare coverage for Medtronic's renal denervation therapy for high blood pressure, signaling a key step toward ...
3d
GlobalData on MSNGeneticure’s test obtains US patent to predict renal denervation responseThe patented method uses genetic markers and a weighted algorithm to assess the responsiveness to renal denervation.
8h
Zacks Investment Research on MSNHospital Capex Headwind: Temporary Setback or Lasting Risk for ISRG?Intuitive Surgical ISRG entered 2025 with strong momentum — da Vinci system placements grew 17% year over year and procedures ...
Medtronic and Recor Medical both issued statements supporting new Medicare coverage for their respective renal denervation ...
Medtronic is studying the use of its nitinol-enabled Symplicity Spyral renal denervation (RDN) catheter combined with hepatic ...
The Centers for Medicare & Medicaid Services (CMS) issued a proposed decision memo for its National Coverage Analysis (NCA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results